These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19915710)

  • 21. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.
    Staevska M; Popov TA; Kralimarkova T; Lazarova C; Kraeva S; Popova D; Church DS; Dimitrov V; Church MK
    J Allergy Clin Immunol; 2010 Mar; 125(3):676-82. PubMed ID: 20226302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desloratadine for the Relief of Nasal and Non-nasal Allergy Symptoms: An Observational Study.
    Aberer W
    Arch Drug Inf; 2009 Jun; 2(2):17-22. PubMed ID: 19684848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.
    Nettis E; Colanardi MC; Paradiso MT; Ferrannini A
    Clin Exp Allergy; 2004 Sep; 34(9):1401-7. PubMed ID: 15347373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years.
    Potter P; Mitha E; Barkai L; Mezei G; Santamaría E; Izquierdo I; Maurer M
    Pediatr Allergy Immunol; 2016 Feb; 27(1):55-61. PubMed ID: 26267219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life.
    Grob JJ; Auquier P; Dreyfus I; Ortonne JP
    Allergy; 2009 Apr; 64(4):605-12. PubMed ID: 19133920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Desloratadine: a nonsedating antihistamine.
    Limon L; Kockler DR
    Ann Pharmacother; 2003 Feb; 37(2):237-46; quiz 313-6. PubMed ID: 12549956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of desloratadine syrup in children.
    Bloom M; Staudinger H; Herron J
    Curr Med Res Opin; 2004 Dec; 20(12):1959-65. PubMed ID: 15701213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of allergic rhinitis with desloratadine: results of a multinational observational study in the middle East gulf region.
    Adham TM
    World Allergy Organ J; 2011 Aug; 4(8):130-4. PubMed ID: 23282541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis.
    Pradalier A; Neukirch C; Dreyfus I; Devillier P
    Allergy; 2007 Nov; 62(11):1331-4. PubMed ID: 17521311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized controlled trial of desloratadine for persistent allergic rhinitis: correlations between symptom improvement and quality of life.
    Bousquet J; Zuberbier T; Canonica GW; Fokkens WJ; Gopalan G; Shekar T
    Allergy Asthma Proc; 2013; 34(3):274-82. PubMed ID: 23676577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.
    Berger WE; Schenkel EJ; Mansfield LE;
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ebastine in allergic rhinitis and chronic idiopathic urticaria.
    Sastre J
    Allergy; 2008 Dec; 63 Suppl 89():1-20. PubMed ID: 19032340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of desloratadine 5 mg once daily in patients with symptoms of seasonal allergic rhinitis: results of a Canadian multicenter, open-label trial.
    Keith PK; Luciuk G
    Clin Ther; 2007 Mar; 29(3):419-26. PubMed ID: 17577463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria.
    Finn AF; Kaplan AP; Fretwell R; Qu R; Long J
    J Allergy Clin Immunol; 1999 Nov; 104(5):1071-8. PubMed ID: 10550755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic urticaria: impact of allergic inflammation.
    Hein R
    Allergy; 2002; 57 Suppl 75():19-24. PubMed ID: 12492725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Desloratadine treatment for intermittent and persistent allergic rhinitis: a review.
    Bachert C; van Cauwenberge P
    Clin Ther; 2007 Sep; 29(9):1795-802. PubMed ID: 18035184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Desloratadine: an update of its efficacy in the management of allergic disorders.
    Murdoch D; Goa KL; Keam SJ
    Drugs; 2003; 63(19):2051-77. PubMed ID: 12962522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of the evidence from comparative studies of levocetirizine and desloratadine for the symptoms of allergic rhinitis.
    Passalacqua G; Canonica GW
    Clin Ther; 2005 Jul; 27(7):979-92. PubMed ID: 16154477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validity and responsiveness of the Urticaria Activity and Impact Measure: A new patient-reported tool.
    Maurer M; Mathias SD; Crosby RD; Rajput Y; Zazzali JL
    Ann Allergy Asthma Immunol; 2018 Jun; 120(6):641-647. PubMed ID: 29567359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.